TEMSIROLIMUS-RESISTANT, CHECKPOINT-DEFICIENT, HOMEOSTATIC CYTOKINE-RESPONSIVE AUTOLOGOUS TH1/TC1 CELLS FOR THERAPY OF RELAPSED, REFRACTORY MULTIPLE MYELOMA (RRMM)
Cytotherapy（2021）
Key words
checkpoint,multiple myeloma,mTOR
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined